Correction to: High Prevalence of Fecal Carriage of Extended Spectrum β-Lactamase-Producing Enterobacteriaceae Among Newly HIV-Diagnosed Adults in a Community Setting in Tanzania, by Manyahi J, et al. Microb Drug Resist 2020;26(12):1540-1545; DOI: 10.1089/mdr.2020.0066.

Abstract

Microbial Drug ResistanceVol. 27, No. 2 CorrectionOpen AccessCorrection to: High Prevalence of Fecal Carriage of Extended Spectrum β-Lactamase-Producing Enterobacteriaceae Among Newly HIV-Diagnosed Adults in a Community Setting in Tanzania, by Manyahi J, et al. Microb Drug Resist 2020;26(12):1540–1545; DOI: 10.1089/mdr.2020.0066is erratum ofHigh Prevalence of Fecal Carriage of Extended Spectrum β-Lactamase-Producing Enterobacteriaceae Among Newly HIV-Diagnosed Adults in a Community Setting in TanzaniaPublished Online:1 Feb 2021https://doi.org/10.1089/mdr.2020.0066.correxAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail In the December 2020 issue of Microbial Drug Resistance (vol. 26, no. 12; pages 1540–1545) the article entitled, High Prevalence of Fecal Carriage of Extended Spectrum β-Lactamase-Producing Enterobacteriaceae Among Newly HIV-Diagnosed Adults in a Community Setting in Tanzania, by Joel Manyahi, Sabrina John Moyo, Marit Gjerde Tellevik, Nina Langeland, and Bjørn Blomberg, requires two corrections in the article's Abstract.In the original article, on page 1540, the fourth line of the Abstract read:“A total of 595 newly diagnosed HIV adults with a median age of 35 years with interquartile range (IQR) 29–42 years and a median CD4 count of 492 cells/μL (IQR 390–666 cells/μL) were recruited.”It should have appeared as:“A total of 595 newly diagnosed HIV-positiveadults with a median age of 35 years with interquartile range (IQR) 29–42 years and a median CD4 count of 492 cells/μL (IQR 390–666 cells/μL) were recruited.”In the original article, the ninth line of the Abstract appeared as:“Antibiotic use in last 4 weeks (odds ratio [OR] 1.55, 95% CI 1.08–2.22, p = 0.02) and CD4 count ≥350 cells/μL (OR 1.78, 95% CI 1.03–3.09, p = 0.04) were independent risk factors for fecal carriage of ESBL-PE.”It should have appeared as:“Antibiotic use in last 4 weeks (odds ratio [OR] 1.55, 95% CI 1.08–2.22, p = 0.02) and CD4 count <350 cells/mL (OR 1.78, 95% CI 1.03–3.09, p = 0.04) were independent risk factors for fecal carriage of ESBL-PE.”The online version has been corrected to reflect this. The authors apologize for the error.FiguresReferencesRelatedDetailsRelated articlesHigh Prevalence of Fecal Carriage of Extended Spectrum β-Lactamase-Producing Enterobacteriaceae Among Newly HIV-Diagnosed Adults in a Community Setting in Tanzania3 Dec 2020Microbial Drug Resistance Volume 27Issue 2Feb 2021 InformationCopyright 2021, Mary Ann Liebert, Inc., publishersTo cite this article:Correction to: High Prevalence of Fecal Carriage of Extended Spectrum β-Lactamase-Producing Enterobacteriaceae Among Newly HIV-Diagnosed Adults in a Community Setting in Tanzania, by Manyahi J, et al. Microb Drug Resist 2020;26(12):1540–1545; DOI: 10.1089/mdr.2020.0066.Microbial Drug Resistance.Feb 2021.277-277.http://doi.org/10.1089/mdr.2020.0066.correxcreative commons licensePublished in Volume: 27 Issue 2: February 1, 2021Online Ahead of Print:January 25, 2021PDF download